about
In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities.Exploring the effect of PARP-1 flexibility in docking studies.Distant polypharmacology among MLP chemical probes.canSAR: an updated cancer research and drug discovery knowledgebase.Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors.Identification of pim kinases as novel targets for PJ34 with confounding effects in PARP biology.Dual Inhibitors of PARPs and ROCKsMeeting Proceedings from ICBS 2018- Toward Translational ImpactThe kinase polypharmacology landscape of clinical PARP inhibitorsPublic resources for chemical probes: the journey so far and the road aheadTransforming cancer drug discovery with Big Data and AI
P50
Q34466574-9E1C4044-2CCC-48B3-A2D6-86381DDE4E38Q34993719-2498348E-CBC1-474A-9F45-8BB315AD0876Q35388534-F2274EF0-31EB-47B4-ADF1-405697779DADQ38811457-C90AD415-020A-4CC2-883C-300AE2CD2B0FQ42739081-63662755-D8C0-49EA-B3D4-86646B991D59Q54480627-F4848849-75CC-4357-9F4A-8E7C7C1914C1Q58581240-0C12743D-F5C3-4E26-BEAD-78972E4902E1Q64113705-4DC0BF12-1D40-4BCE-8650-066E80A22E00Q89747982-ECAD5271-AEB2-4467-9C39-60C6F952998FQ91506468-435AB7EE-BD47-4D26-A349-AC98F4C22369Q91717195-A2230924-6067-4AFE-856F-334460E7863C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Albert A Antolín
@ast
Albert A Antolín
@en
Albert A Antolín
@es
Albert A Antolín
@nl
type
label
Albert A Antolín
@ast
Albert A Antolín
@en
Albert A Antolín
@es
Albert A Antolín
@nl
prefLabel
Albert A Antolín
@ast
Albert A Antolín
@en
Albert A Antolín
@es
Albert A Antolín
@nl
P106
P21
P31
P496
0000-0002-1634-9034